Abram Scientific Awarded Up To $8.3 Million under a DARPA Contract to Advance Rapid, Portable Blood Coagulation Diagnostics for Trauma Care
MENLO PARK, Calif., Oct. 13, 2026 — Abram Scientific, a medical device company focused on advancing next-generation coagulation diagnostics, today announced that it has been awarded a contract of up to $8.3 million from the Defense Advanced Research Projects Agency (DARPA) to advance i...